Nutrients and botanicals for treatment of stress: Adrenal fatigue, neurotransmitter imbalance, anxiety, and restless sleep

Alternative Medicine Review

Volumn 14, Issue 2, 2009, Pages 114-140

  Head, Kathleen A ^a   Kelly, Gregory S ^b  

^a Thorne Research Incorporated   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADAPT 232; APIGENIN; BACOPA MONNIERI EXTRACT; CORTICOSTEROID DERIVATIVE; DIAZEPAM; ELEUTHEROCOCCUS SENTICOSUS EXTRACT; FISH OIL; GINSENG EXTRACT; GLYCYRRHIZA EXTRACT; GLYCYRRHIZA GLABRA EXTRACT; GLYCYRRHIZA URALENSIS EXTRACT; HUMULUS LUPULUS EXTRACT; KAVA EXTRACT; LORAZEPAM; MATRICARIA CHAMOMILLA EXTRACT; MELISSA OFFICINALIS EXTRACT; NATURAL PRODUCT; OXAZEPAM; PASSIFLORA INCARNATA EXTRACT; PHOSPHATIDYLSERINE; PLACEBO; RHODAX; RHODIOLA EXTRACT; RHODIOLA ROSEA EXTRACT; STEROL DERIVATIVE; STEROLIN DERIVATIVE; THEANINE; THIOCTIC ACID; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALERIAN; WITHANIA SOMNIFERA EXTRACT;

ADDISON DISEASE; AMNESIA; ANTIOXIDANT ACTIVITY; ANXIETY DISORDER; ASTHENIA; BACOPA MONNIERI; BEDTIME DOSAGE; CHRONIC STRESS; CLINICAL TRIAL; CYTOTOXICITY; DRUG DOSE COMPARISON; DRUG DOSE REDUCTION; DRUG MECHANISM; ELEUTHEROCOCCUS SENTICOSUS; FATIGUE; GENERALIZED ANXIETY DISORDER; GINSENG; GLYCYRRHIZA GLABRA; GLYCYRRHIZA URALENSIS; HUMAN; HUMORAL IMMUNITY; HUMULUS LUPULUS; HYPERTENSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSOMNIA; INTESTINE FLORA; MATRICARIA; MELISSA OFFICINALIS; MEMORY DISORDER; MENTAL STRESS; MOOD DISORDER; MUSCLE TONE; NATURAL KILLER CELL; NEUROTRANSMITTER RELEASE; NONHUMAN; OXIDATIVE STRESS; RESTLESSNESS; REVIEW; RHODIOLA; SIDE EFFECT; SLEEP DISORDER; STRESS MANAGEMENT; TRANQUILIZING ACTIVITY; UNSPECIFIED SIDE EFFECT; VALERIANA OFFICINALIS; WATER RETENTION; WITHANIA SOMNIFERA;

DRUGS, CHINESE HERBAL; FISH OILS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; PHYTOTHERAPY; PITUITARY-ADRENAL SYSTEM; PLANT EXTRACTS; PLANTS, MEDICINAL; STRESS, PHYSIOLOGICAL; TRACE ELEMENTS; TYROSINE; VITAMINS;

EID: 67650964078     PISSN: 10895159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (227)

1. http://www.stress.org/americas.htm [Accessed March 13, 2009]
2. http://www.apa.org/topics/topicstress.html [Accessed March 13, 2009]
3. Opstad K. Circadian rhythm of hormones is extinguished during prolonged physical stress, sleep and energy deficiency in young men. Eur J Endocrinol 1994;131:56-66. (Pubitemid 24230553)
4. Palmblad J, Levi L, Burger A, et al. Effects of total energy withdrawal (fasting) on the levels of growth hormone, thyrotropin, cortisol, adrenaline, noradrenaline, T4, T3, and rT3 in healthy males. Acta Med Scand 1977;201:15-22.
5. Shimizu H, Miyazaki M, Shimomura Y, Kobayashi I. Altered hormonal status in a female deprived of food for 18 days. J Med 1991;22:201-210.
6. Tegelman R, Lindeskog P, Carlstrom K, et al. Peripheral hormone levels in healthy subjects during controlled fasting. Acta Endocrinol (Copenh) 1986;113:457-462. (Pubitemid 17178831)
7. Beer SF, Bircham PM, Bloom SR, et al. The effect of a 72-h fast on plasma levels of pituitary, adrenal, thyroid, pancreatic and gastrointestinal hormones in healthy men and women. J Endocrinol 1989; 120:337-350. (Pubitemid 19042726)
8. Vinogradov VV, Tarasov IuA, Tishin VS, et al. Thiamine prevention of the corticosteroid reaction after surgery. Probl Endokrinol (Mosk) 1981;27:11-16. [Article in Russian]
9. von Treuer K, Norman TR, Armstrong SM. Overnight human plasma melatonin, cortisol, prolactin, TSH, under conditions of normal sleep, sleep deprivation, and sleep recovery. J Pineal Res 1996;20:7-14. (Pubitemid 126732260)
10. Leproult R, Van Reeth O, Byrne MM, et al. Sleepiness, performance, and neuroendocrine function during sleep deprivation: effects of exposure to bright light or exercise. J Biol Rhythms 1997;12:245-258. (Pubitemid 127477082)
11. Bosco C, Tihanyl J, Rivalta L, et al. Hormonal responses in strenuous jumping effort. Jpn J Physiol 1996;46:93-98. (Pubitemid 26150403)
12. Semple CG, Thomson JA, Beastall GH. Endocrine responses to marathon running. Br J Sports Med 1985;19:148-151.
13. Dessypris A, Wagar G, Fyhrquist F, et al. Marathon run: effects on blood cortisol - ACTH, iodothyronines - TSH and vasopressin. Acta Endocrinol (Copenh) 1980;95:151-157. (Pubitemid 11218629)
14. Irwin M, Daniels M, Risch SC, et al. Plasma cortisol and natural killer cell activity during bereavement. Biol Psychiatry 1988;24:173-178. (Pubitemid 18137513)
15. Rein G, Atkinson M, McCraty R. The physiological and psychological effects of compassion and anger. J Adv Med 1995;8:87-105.
16. Esterling BA, Kiecolt-Glaser JK, Bodnar JC, Glaser R. Chronic stress, social support, and persistent alterations in the natural killer cell response to cytokines in older adults. Health Psychol 1994;13:291-298.
17. Kiecolt-Glaser JK, Glaser R, Cacioppo JT, Malarkey WB. Marital stress: immunologic, neuroendocrine, and autonomic correlates. Ann N Y Acad Sci 1998;840:656-663. (Pubitemid 28302091)
18. Allison TG, Williams DE, Miller TD, et al. Medical and economic costs of psychologic distress in patients with coronary artery disease. Mayo Clin Proc 1995;70:734-742.
19. Mittleman MA, Maclure M, Sherwood JB, et al. Triggering of acute myocardial infarction onset by episodes of anger. Determinants of Myocardial Infarction Onset Study Investigators. Circulation 1995;92:1720-1725.
20. Kawachi I, Sparrow D, Spiro A 3rd, et al. A prospective study of anger and coronary heart disease. The Normative Aging Study. Circulation 1996;94:2090-2095.
21. Kawachi I, Sparrow D, Vokonas PS, Weiss ST. Symptoms of anxiety and risk of coronary heart disease. The Normative Aging Study. Circulation 1994;90:2225-2229.
22. Kubzansky LD, Kawachi I, Spiro A 3rd, et al. Is worrying bad for your heart? A prospective study of worry and coronary heart disease in the Normative Aging Study. Circulation 1997;95:818-824.
23. Kusaka Y, Morimoto K. Does lifestyle modulate natural killer cell activities? Nippon Eiseigaku Zasshi 1992;46:1035-1042. [Article in Japanese]
24. Strauman TJ, Lemieux AM, Coe CL. Self-discrepancy and natural killer cell activity: immunological consequences of negative self-evaluation. J Pers Soc Psychol 1993;64:1042-1052.
25. Sieber WJ, Rodin J, Larson L, et al. Modulation of human natural killer cell activity by exposure to uncontrollable stress. Brain Behav Immun 1992;6:141-156.
26. Irwin M, Patterson T, Smith TL, et al. Reduction of immune function in life stress and depression. Biol Psychiatry 1990;27:22-30. (Pubitemid 20035217)
27. Andersen BL, Farrar WB, Golden-Kreutz D, et al. Stress and immune responses after surgical treatment for regional breast cancer. J Natl Cancer Inst 1998;90:30-36. (Pubitemid 28078078)
28. Pike JL, Smith TL, Hauger RL, et al. Chronic life stress alters sympathetic, neuroendocrine, and immune responsivity to an acute psychological stressor in humans. Psychosom Med 1997;59:447-457. (Pubitemid 27315247)
29. Jemmott JB 3d, Magloire K. Academic stress, social support, and secretory immunoglobulin A. J Pers Soc Psychol 1988;55:803-810.
30. McClelland DC, Ross G, Patel V. The effect of an academic examination on salivary norepinephrine and immunoglobulin levels. J Human Stress 1985;11:52-59. (Pubitemid 15241217)
31. Jemmott JB 3d, Borysenko JZ, Borysenko M, et al. Academic stress, power motivation, and decrease in secretion rate of salivary secretory immunoglobulin A. Lancet 1983;1:1400-1402.
32. Jemmott JB 3d, McClelland DC. Secretory IgA as a measure of resistance to infectious disease: comments on Stone, Cox, Valdimarsdottir, and Neale. Behav Med 1989;15:63-71.
33. McClelland DC, Floor E, Davidson RJ, Saron C. Stressed power motivation, sympathetic activation, immune function, and illness. J Human Stress 1980;6:11-19. (Pubitemid 10071431)
34. Martin RA, Dobbin JP. Sense of humor, hassles, and immunoglobulin A: evidence for a stress-moderating effect of humor. Int J Psychiatry Med 1988;18:93-105. (Pubitemid 18214264)
35. Huis in't Veld JH. Gastrointestinal flora and health in man and animal. Tijdschr Diergeneeskd 1991;116:232-239. [Article in Dutch]
36. Moore WE, Cato EP, Holdeman LV. Some current concepts in intestinal bacteriology. Am J Clin Nutr 1978;31:S33-S42. (Pubitemid 9058925)
37. Lizko NN, Silov VM, Syrych GD. Events in the development of dysbacteriosis of the intestines in man under extreme conditions. Nahrung 1984;28:599-605. [Article in German]
38. Davydov M, Krikorian AD. Eleutherococcus senticosus (Rupr. & Maxim.) Maxim. (Araliaccae) as an adaptogen: a closer look. J Ethnopharmacol 2000;72:345-393. (Pubitemid 30734671)
39. Banerjee U, Izquierdo JA. Antistress and antifatigue properties of Panax ginseng; comparison with piracetam. Acta Physiol Lat Am 1982;32:277-285.
40. Saito H, Yoshida Y, Takagi K. Effect of Panax ginseng root on exhaustive exercise in mice. Jpn J Pharmacol 1974;24:119-127.
41. Takahashi M, Tokuyama S, Kaneto H. Anti-stress effect of ginseng on the inhibition of the development of morphine tolerance in stressed mice. Jpn J Pharmacol 1992;59:399-404.
42. Grandhi A, Mujumdar AM, Patwardhan B. A comparative pharmacological investigation of ashwagandha and ginseng. J Ethnopharmacol 1994;44:131-135.
43. Huong NT, Matsumoto K, Watanabe H. The antistress effect of majonoside-R2, a major saponin component of Vietnamese ginseng: neuronal mechanisms of action. Methods Find Exp Clin Pharmacol 1998;20:65-76. (Pubitemid 28162656)
44. Kumar R, Grover SK, Divekar HM, et al. Enhanced thermogenesis in rats by Panax ginseng, multivitamins and minerals. Int J Biometeorol 1996;39:187-191. (Pubitemid 126428401)
45. Buffi O, Ciaroni S, Guidi L, et al. Morphological analysis on the adrenal zona fasciculata of ginseng, ginsenoside Rb1 and ginsenoside Rg1 treated mice. Boll Soc Ital Biol Sper 1993;69:791-797.
46. Luo YM, Cheng XJ, Yuan WX. Effects of ginseng root saponins and ginsenoside Rb1 on immunity in cold water swim stress mice and rats. Zhongguo Yao Li Xue Bao 1993;14:401-404.
47. Ng TB, Li WW, Yeung HW. Effects of ginsenosides, lectins and Momordica charantia insulin-like peptide on corticosterone production by isolated rat adrenal cells. J Ethnopharmacol 1987;21:21-29. (Pubitemid 18082810)
48. Hiai S, Yokoyama H, Oura H, Yano S. Stimulation of pituitary- adrenocortical system by ginseng saponin. Endocrinol Jpn 1979;26:661-665. (Pubitemid 10105137)
49. Fulder SJ. Ginseng and the hypothalamic-pituitary control of stress. Am J Chin Med 1981;9:112-118.
50. Caso Marasco A, Vargas Ruiz R, Salas Villagomez A, Begona Infante C. Double-blind study of a multivitamin complex supplemented with ginseng extract. Drugs Exp Clin Res 1996;22:323-329. (Pubitemid 27060181)
51. Gaffney BT, Hugel HM, Rich PA. The effects of Eleutherococcus senticosus and Panax ginseng on steroidal hormone indices of stress and lymphocyte subset numbers in endurance athletes. Life Sci 2001;70:431-442. (Pubitemid 34017537)
52. Nishibe S, Kinoshita H, Takeda H, Okano G. Phenolic compounds from stem bark of Acanthopanax senticosus and their pharmacological effect in chronic swimming stressed rats. Chem Pharm Bull (Tokyo) 1990;38:1763-1765. (Pubitemid 20265675)
53. Golotin VG, Gonenko VA, Zimina VV, et al. Effect of ionol and eleutherococcus on changes of the hypophysea-adrenal system in rats under extreme conditions. Vopr Med Khim 1989;35:35-37. (Pubitemid 19031759)
54. Filaretov AA, Bogdanova TS, Mitiushov MI, et al. Effect of adaptogens on the activity of the pituitary-adrenocortical system in rats. Biull Eksp Biol Med 1986;101:573-574. [Article in Russian] (Pubitemid 16078891)
55. Farnsworth NR, Kinghorn AD, Soejarto D, Waller DP. Siberian ginseng (Eleutherococcus senticosus): current status as an adaptogen. Econ Med Plant Res 1985;1:156-215.
56. Facchinetti F, Neri I, Tarabusi M. Eleutherococcus senticosus reduces cardiovascular response in healthy subjects: a randomized, placebo-controlled trial. Stress Health 2002;18:11-17. (Pubitemid 34173072)
57. Armanini D, Karbowiak I, Funder JW. Affinity of licorice derivatives for mineralocorticoid and glucocorticoid receptors. Clin Endocrinol (Oxf) 1983;19:609-612. (Pubitemid 14226000)
58. Kuroyanagi T, Saito M. Effect of prednisolone and glycyrrhizin on passive transfer in experimental allergic encephalomyelitis. Arerugi 1966;15:67-74. [Article in Japanese]
59. Kumagai A, Nanaboshi M, Asanuma Y, et al. Effects of glycyrrhizin on thymolytic and immunosuppressive action of cortisone. Endocrinol Jpn 1967;14:39-42.
60. Adamyan TI, Gevorkyan ES, Minasyan SM, et al. Effect of licorice root on peripheral blood indexes upon vibration exposure. Bull Exp Biol Med 2005;140:197-200. (Pubitemid 43019319)
61. Belanger CA. The Chinese Herb Selection Guide: A Traditional and Modern Clinical Repertory with a Summary Materia Medica for the Health Care Practitioner. Richmond, CA: Phytotech Databased Publishing Co.; 1997:763-764.
62. Forslund T, Fyhrquist F, Froseth B, Tikkanen I. Effects of licorice on plasma atrial natriuretic peptide in healthy volunteers. J Intern Med 1989;225:95-99. (Pubitemid 19119713)
63. Archana R, Namasivayam A. Antistressor effect of Withania somnifera. J Ethnopharmacol 1999;64:91-93.
64. Dhuley JN. Effect of ashwagandha on lipid peroxidation in stress-induced animals. J Ethnopharmacol 1998;60:173-178. (Pubitemid 28143728)
65. Elsakka M, Pavelescu M, Grigorescu E. Withania somnifera, a plant with a great therapeutical future. Rev Med Chir Soc Med Nat Iasi 1989;93:349-350.
66. Gupta GL, Rana AC. Protective effect of Withania somnifera Dunal root extract against protracted social isolation induced behavior in rats. Indian J Physiol Pharmacol 2007;51:345-353.
67. Bhattacharya SK, Muruganandam AV. Adaptogenic activity of Withania somnifera: an experimental study using a rat model of chronic stress. Pharmacol Biochem Behav 2003;75:547-555. (Pubitemid 36936889)
68. Kuttan G. Use of Withania somnifera Dunal as an adjuvant during radiation therapy. Indian J Exp Biol 1996;34:854-856. (Pubitemid 26289496)
69. Ziauddin M, Phansalkar N, Patki P, et al. Studies on the immunomodulatory effects of ashwagandha. J Ethnopharmacol 1996;50:69-76.
70. Stancheva SL, Mosharrof A. Effect of the extract of Rhodiola rosea L. on the content of the brain biogenic monamines. Med Physiol 1987;40:85-87.
71. Maslova LV, Kondrat'ev BIu, Maslov LN, Lishmanov IuB. The cardioprotective and antiadrenergic activity of an extract of Rhodiola rosea in stress. Eksp Klin Farmakol 1994;57:61-63. [Article in Russian]
72. Lishmanov IuB, Trifonova ZhV, Tsibin AN, et al. Plasma beta-endorphin and stress hormones in stress and adaptation. Biull Eksp Biol Med 1987;103:422-424. [Article in Russian]
73. Lishmanov IB, Maslova LV, Maslov LN, Dan'shina EN. The anti-arrhythmia effect of Rhodiola rosea and its possible mechanism. Biull Eksp Biol Med 1993;116:175-176. [Article in Russian]
74. Maimeskulova LA, Maslov LN, Lishmanov IuB, Krasnov EA. The participation of the mu-, delta- and kappa-opioid receptors in the realization of the anti-arrhythmia effect of Rhodiola rosea. Eksp Klin Farmakol 1997;60:38-39. [Article in Russian]
75. Lishmanov IB, Naumova AV, Afanas'ev SA, Maslov LN. Contribution of the opioid system to realization of inotropic effects of Rhodiola rosea extracts in ischemic and reperfusion heart damage in vitro. Eksp Klin Farmakol 1997;60:34-36. [Article in Russian]
76. Maimeskulova LA, Maslov LN. The anti-arrhythmia action of an extract of Rhodiola rosea and of n-tyrosol in models of experimental arrhythmias. Eksp Klin Farmakol 1998;61:37-40. [Article in Russian]
77. Afanas'ev SA, Alekseeva ED, Bardamova IB, et al. Cardiac contractile function following acute cooling of the body and the adaptogenic correction of its disorders. Biull Eksp Biol Med 1993;116:480-483. [Article in Russian]
78. Maslova LV, Lishmanov IuB, Maslov LN. Cardioprotective effects of adaptogens of plant origin. Biull Eksp Biol Med 1993;115:269-271. [Article in Russian] (Pubitemid 23266574)
79. Mattioli L, Funari C, Perfumi M. Effects of Rhodiola rosea L. extract on behavioural and physiological alterations induced by chronic mild stress in female rats. J Psychopharmacol 2009;23:130-142.
80. Germano C, Ramazanov Z, Bernal Suarez M. Arctic Root (Rhodiola rosea): The Powerful New Ginseng Alternative. New York, NY: Kensington Publishing Corp; 1999.
81. Bystritsky A, Kerwin L, Feusner JD. A pilot study of Rhodiola rosea (Rhodax) for generalized anxiety disorder (GAD). J Altern Complement Med 2008;14:175-180.
82. Olsson EM, von Scheele B, Panossian AG. A randomised, double-blind, placebo-controlled, parallel-group study of the standardised extract SHR-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue. Planta Med 2009;75:105-112.
83. Darbinyan V, Kteyan A, Panossian A, et al. Rhodiola rosea in stress induced fatigue - a double blind cross-over study of a standardized extract SHR-5 with a repeated low-dose regimen on the mental performance of healthy physicians during night duty. Phytomedicine 2000;7:365-371. (Pubitemid 30781317)
84. Spasov AA, Wikman GK, Mandrikov VB, et al. A double-blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR-5 extract on the fatigue of students caused by stress during an examination period with a repeated low-dose regimen. Phytomedicine 2000;7:85-89. (Pubitemid 30307605)
85. Panossian A, Wikman G, Kaur P, Asea A. Adaptogens exert a stress-protective effect by modulation of expression of molecular chaperones. Phytomedicine 2009 Jan 31. [Epub ahead of print]
86. Schutgens FW, Neogi P, van Wijk EP, et al. The influence of adaptogens on ultraweak biophoton emission: a pilot-experiment. Phytother Res 2009 Jan 23. [Epub ahead of print]
87. Fahey TD, Pearl MS. The hormonal and perceptive effects of phosphatidylserine administration during two weeks of resistive exercise-induced overtraining. Biol Sport 1998;15:135-144. (Pubitemid 128539912)
88. Monteleone P, Beinat L, Tanzillo C, et al. Effects of phosphatidylserine on the neuroendocrine response to physical stress in humans. Neuroendocrinology 1990;52:243-248. (Pubitemid 20260125)
89. Monteleone P, Maj M, Beinat L, et al. Blunting by chronic phosphatidylserine administration of the stress-induced activation of the hypothalamo-pituitary-adrenal axis in healthy men. Eur J Clin Pharmacol 1992;42:385-388.
90. Starks MA, Starks SL, Kingsley M, et al. The effects of phosphatidylserine on endocrine response to moderate intensity exercise. J Int Soc Sports Nutr 2008;5:11.
91. Hellhammer J, Fries E. Buss C, et al. Effects of soy lecithin phosphatidic acid and phosphatidylserine complex (PAS) on the endocrine and psychological responses to mental stress. Stress 2004;7:119-126. (Pubitemid 39013703)
92. Delarue J, Matzinger O, Binnert C, et al. Fish oil prevents the adrenal activation elicited by mental stress in healthy men. Diabetes Metab 2003;29:289-295. (Pubitemid 36807440)
93. Hamazaki K, Itomura M, Huan M, et al. Effect of omega-3 fatty acid-containing phospholipids on blood catecholamine concentrations in healthy volunteers: a randomized, placebo-controlled, double-blind trial. Nutrition 2005;21:705-710. (Pubitemid 40733565)
94. Hamazaki T, Itomura M, Sawazaki S, Nagao Y. Anti-stress effects of DHA. Biofactors 2000;13:41-45.
95. Bouic PJ, Clark A, Lamprecht J, et al. The effects of β-sitosterol (BSS) and β-sitosterol glucoside (BSSG) mixture on selected immune parameters of marathon runners: inhibition of post marathon immune suppression and inflammation. Int J Sports Med 1999;20:258-262. (Pubitemid 29225021)
96. Ohmori H, Yamauchi T, Yamamoto I. Augmentation of the antibody response by lipoic acid in mice. II. Restoration of the antibody response in immunosuppressed mice. Jpn J Pharmacol 1986;42:275-280. (Pubitemid 16021031)
97. Fomichev VI, Pchelintsev VP. The neurohumoral systems of patients with ischemic heart disease and under emotional-pain stress: the means for their pharmacological regulation. Kardiologiia 1993;33:15-18. [Article in Russian]
98. Yokogoshi H, Kobayashi M, Mochizuki M, Terashima T. Effect of theanine, R-glutamylethylamide, on brain monoamines and striatal dopamine release in conscious rats. Neurochem Res 1998;23:667-673. (Pubitemid 28173572)
99. Yamada T, Terashima T, Kawano S, et al. Theanine, gamma- glutamylethylamide, a unique amino acid in tea leaves, modulates neurotransmitter concentrations in the brain striatum interstitium in conscious rats. Amino Acids 2009;36:21-27.
100. Kakuda T, Nozawa A, Unno T, et al. Inhibiting effects of theanine on caffeine stimulation evaluated by EEG in the rat. Biosci Biotechnol Biochem 2000;64:287-293.
101. Ito K, Nagato Y, Aoi N, et al. Effects of L-theanine on the release of alpha-brain waves in human volunteers. Nippon Nogeikagaku Kaishi 1998;72:153-157. (Pubitemid 128660906)
102. Nobre AC, Rao A, Owen GN. L-theanine, a natural constituent in tea, and its effect on mental state. Asia Pac J Clin Nutr 2008;17:167-168.
103. Kimura K, Ozeki M, Juneja LR, Ohira H. L-theanine reduces psychological and physiological stress responses. Biol Psychol 2007;74:39-45. (Pubitemid 44781395)
104. Bhattacharya SK, Ghosal S. Anxiolytic activity of a standardized extract of Bacopa monniera in an experimental study. Phytomedicine 1998;5:77-82. (Pubitemid 128566305)
105. Singh RH, Singh L. Studies on the anti-anxiety effect of the Medyha Rasayana drug, Brahmi (Bacopa monniera Wettst.) - Part 1. J Res Ayur Siddha 1980;1:133-148.
106. Stough C, Lloyd J, Clarke J, et al. The chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy human subjects. Psychopharmacology (Berl) 2001;156:481-484. (Pubitemid 32695859)
107. Calabrese C, Gregory WL, Leo M, et al. Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial. J Altern Complement Med 2008;14:707-713.
108. Weiss RF, Fintelmann V. Herbal Medicine. 2nd ed. Stuttgart, Germany: Thieme; 2000:262-263.
109. Houghton PJ. The scientific basis for the reputed activity of valerian. J Pharm Pharmacol 1999;51:505-512. (Pubitemid 29319774)
110. Hendriks H, Bos R, Allersma DP, et al. Pharmacological screening of valerenal and some other components of essential oil of Valeriana officinalis. Planta Med 1981;42:62-68. (Pubitemid 11077172)
111. Neuhaus W, Trauner G, Gruber D, et al. Transport of a GABAA receptor modulator and its derivatives from Valeriana officinalis L. s. I. across an in vitro cell culture model of the blood-brain barrier. Planta Med 2008;74:1338-1344.
112. Cavadas C, Araujo I, Cotrim MD, et al. In vitro study on the interaction of Valeriana officinalis L. extracts and their amino acids on GABAA receptor in rat brain. Arzneimittelforschung 1995;45:753-755.
113. Ortiz JG, Nieves-Natal J, Chavez P. Effects of Valeriana officinalis extracts on [3H]flunitrazepam binding, synaptosomal [3H]GABA uptake, and hippocampal [3H]GABA release. Neurochem Res 1999;24:1373-1378. (Pubitemid 129723674)
114. Riedel E, Hansel R, Ehrke G. Inhibition of gamma-aminobutyric acid catabolism by valerenic acid derivatives. Planta Med 1982;46:219-220. [Article in German]
115. Santos MS, Ferreira F, Faro C, et al. The amount of GABA present in aqueous extracts of valerian is sufficient to account for [3H]GABA release in synaptosomes. Planta Med 1994;60:475-476.
116. Santos MS, Ferreira F, Cunha AP, et al. An aqueous extract of valerian influences the transport of GABA in synaptosomes. Planta Med 1994;60:278-279. (Pubitemid 24207726)
117. Bodesheim U, Holzl J. Isolation and receptor binding properties of alkaloids and lignans from Valeriana officialis L. Pharmazie 1997;52:386-391. [Article in German] (Pubitemid 127489683)
118. Hattesohl M, Feistel B, Sievers H, et al. Extracts of Valeriana officinalis L. s.I show anxiolytic and antidepressant effects but neither sedative nor myorelaxant properties. Phytomedicine 2008;15:2-15. (Pubitemid 50021760)
119. Kohnen R, Oswald WD. The effects of valerian, propranolol, and their combination on activation, performance, and mood of healthy volunteers under social stress conditions. Pharmacopsychiatry 1988;21:447-448. (Pubitemid 19024221)
120. Andreatini R, Sartori VA, Seabra ML, Leite JR. Effect of valepotriates (valerian extract) in generalized anxiety disorder: a randomized placebo-controlled pilot study. Phytother Res 2002;16:650-654. (Pubitemid 35334186)
121. Cropley M, Cave Z, Ellis J, Middleton RW. Effect of kava and valerian on human physiological and psychological responses to mental stress assessed under laboratory conditions. Phytother Res 2002;16:23-27. (Pubitemid 34116690)
122. Leathwood PD, Chauffard F. Aqueous extract of valerian reduces latency to fall asleep in man. Planta Med 1985;51:144-148.
123. Leathwood PD, Chauffard F, Heck E, Munoz-Box R. Aqueous extract of valerian root (Valeriana officinalis L.) improves sleep quality in man. Pharmacol Biochem Behav 1982;17:65-71. (Pubitemid 12040740)
124. Trevena L. Sleepless in Sydney - is valerian an effective alternative to benzodiazepines in the treatment of insomnia? ACPJ Club 2004;141:A14-A16.
125. Donath F, Quispe S, Diefenbach K, et al. Critical evaluation of the effect of valerian extract on sleep structure and sleep quality. Pharmacopsychiatry 2000;33:47-53. (Pubitemid 30161106)
126. Ziegler G, Ploch M, Miettinen-Baumann A, Collet W. Efficacy and tolerability of valerian extract LI 156 compared with oxazepam in the treatment of non-organic insomnia - a randomized, double-blind, comparative clinical study. Eur J Med Res 2002;7:480-486.
127. Poyares DR, Guilleminault C, Ohayon MM, Tufik S. Can valerian improve the sleep of insomniacs after benzodiazepine withdrawal? Prog Neuropsychopharmacol Biol Psychiatry 2002;26:539-545.
128. Dominguez RA, Bravo-Valverde RL, Kaplowitz BR, Cott JM. Valerian as a hypnotic for Hispanic patients. Cultur Divers Ethnic Minor Psychol 2000;6:84-92.
129. Tokunaga S, Takeda Y, Niimoto T, et al. Effect of valerian extract preparation (BIM) on the sleep-wake cycle in rats. Biol Pharm Bull 2007;30:363-366. (Pubitemid 46255370)
130. Speroni E, Minghetti A. Neuropharmacological activity of extracts from Passiflora incarnata. Planta Med 1988;54:488-491. (Pubitemid 19007988)
131. Nassiri-Asl M, Shariati-Rad S, Zamansoltani F. Anticonvulsant effects of aerial parts of Passiflora incarnata extract in mice: involvement of benzodiazepine and opioid receptors. BMC Complement Altern Med 2007;7:26. (Pubitemid 47386803)
132. Grundmann O, Wang J, McGregor GP, Butterweck V. Anxiolytic activity of a phytochemically characterized Passiflora incarnata extract is mediated via the GABAergic system. Planta Med 2008;74:1769-1773.
133. Dhawan K, Kumar S, Sharma A. Comparative anxiolytic activity profile of various preparations of Passiflora incarnata Linneaus: a comment on medicinal plants' standardization. J Altern Complement Med 2002;8:283-291. (Pubitemid 34753403)
134. Akhondzadeh S, Naghavi HR, Vazirian M, et al. Passionflower in the treatment of generalized anxiety: a pilot double-blind randomized controlled trial with oxazepam. J Clin Pharm Ther 2001;26:363-367. (Pubitemid 32989558)
135. Blumenthal M. The Complete German Commission E Monograph: Therapeutic Guide to Herbal Medicines. Austin, TX: American Botanical Council; 1998:147.
136. Fussel A, Wolf A, Brattstrom A. Effect of a fixed valerian-hop extract combination (Ze 91019) on sleep polygraphy in patients with non-organic insomnia: a pilot study. Eur J Med Res 2000;5:385-390.
137. Schmitz M, Jackel M. Comparative study for assessing quality of life of patients with exogenous sleep disorders (temporary sleep onset and sleep interruption disorders) treated with a hops-valarian preparation and a benzodiazepine drug. Wien Med Wochenschr 1998;148:291-298. [Article in German]
138. Viola H, Wasowski C, Levi de Stein M, et al. Apigenin, a component of Matricaria recutita flowers, is a central benzodiazepine receptors-ligand with anxiolytic effects. Planta Med 1995;61:213-216.
139. Loggia RD, Traversa U, Scarcia V, Tubaro A. Depressive effects of Chamomilla recutita (L.) Rausch, tubular flowers, on central nervous system in mice. Pharmacol Res Commun 1982;14:153-162.
140. Gould L, Reddy CV, Gomprecht RF. Cardiac effects of chamomile tea. J Clin Pharmacol 1973;13:475-479.
141. Shinomiya K, Inoue T, Utsu Y, et al. Hypnotic activities of chamomile and Passiflora extracts in sleep-disturbed rats. Biol Pharm Bull 2005;28:808-810. (Pubitemid 40740645)
142. Herrera-Ruiz M, Jimenez-Ferrer JE, De Lima TC, et al. Anxiolytic and antidepressant-like activity of a standardized extract from Galphimia glauca. Phytomedicine 2006;13:23-28. (Pubitemid 41797587)
143. Tortoriello J, Ortega A. Sedative effect of galphimine B, a nor-seco-triterpenoid from Galphimia glauca. Planta Med 1993;59:398-400. (Pubitemid 23319538)
144. Herrera-Ruiz M, Gonzalez-Cortazar M, Jimenez-Ferrer E, et al. Anxiolytic effect of natural galphimines from Galphimia glauca and their chemical derivatives. J Natl Prod 2006;69:59-61. (Pubitemid 43241755)
145. Herrera-Arellano A, Jimenez-Ferrer E, Zamilpa A, et al. Efficacy and tolerability of a standardized herbal product from Galphimia glauca on generalized anxiety disorder. A randomized, double-blind clinical trial controlled with lorazepam. Planta Med 2007;73:713-717.
146. Bradwejn J, Zhou Y, Koszycki D, Shlik J. A double-blind, placebo-controlled study on the effects of gotu kola (Centella asiatica) on acoustic startle response in healthy subjects. J Clin Psychopharmacol 2000;20:680-684. (Pubitemid 30953809)
147. Wattanathorn J, Mator L, Muchimapura S, et al. Positive modulation of cognition and mood in the healthy elderly volunteer following the administration of Centella asiatica. J Ethopharmacol 2008;116:325-332.
148. Wijeweera P, Arnason JT, Koszycki D, Merali Z. Evaluation of anxiolytic properties of gotukola - (Centella asiatica) extracts and asiaticoside in rat behavioral models. Phytomedicine 2006;13:668-676. (Pubitemid 44666404)
149. Awad R, Levac D, Cybulska P, et al. Effects of traditionally used anxiolytic botanicals on enzymes of the gamma-aminobutyric acid (GABA) system. Can J Physiol Pharmacol 2007;85:933-942. (Pubitemid 350189736)
150. Awad R, Muhammad A, Durst T, et al. Bioassay-guided fractionation of lemon balm (Melissa officinalis L.) using an in vitro measure of GABA transaminase activity. Phytother Res 2009 Jan 22. [Epub ahead of print]
151. Kennedy DO, Little W, Haskell CF, Scholey AB. Anxiolytic effects of a combination of Melissa officinalis and Valeriana officinalis during laboratory induced stress. Phytother Res 2006;20:96-102. (Pubitemid 43266832)
152. Muller SF, Klement S. A combination of valerian and lemon balm is effective in the treatment of restlessness and dyssomnia in children. Phytomedicine 2006;13:383-387. (Pubitemid 43744416)
153. Kinzler E, Kromer J, Lehmann E. Effect of a special kava extract in patients with anxiety-, tension-, and excitation states of non-psychotic genesis. Double blind study with placebos over 4 weeks. Arzneimittelforschung 1991;41:584-588. [Article in German]
154. Warnecke G. Psychosomatic dysfunctions in the female climacteric. Clinical effectiveness and tolerance of Kava Extract WS 1490. Fortschr Med 1991;109:119-122. [Article in German]
155. Woelk H, Kapoula S, Lehrl S, et al. Treatment of patients suffering from anxiety - double-blind study: kava special extract versus benzodiazepines. Ztschr Allegemeinmed 1993;69:271-277. (Pubitemid 23296262)
156. Volz HP, Kieser M. Kava-kava extract WS 1490 versus placebo in anxiety disorders - a randomized placebo-controlled 25-week outpatient trial. Pharmacopsychiatry 1997;30:1-5. (Pubitemid 27083460)
157. Heinze HJ, Munthe TF, Steitz J, Matzke M. Pharmacopsychological effects of oxazepam and kava-extract in a visual search paradigm assessed with event-related potentials. Pharmacopsychiatry 1994;27:224-230. (Pubitemid 24337137)
158. Munte TF, Heinze HJ, Matzke M, Steitz J. Effects of oxazepam and an extract of kava roots (Piper methysticum) on event-related potentials in a word recognition task. Neuropsychobiology 1993;27:46-53. (Pubitemid 23165779)
159. Malsch U, Kieser M. Efficacy of kava-kava in the treatment of non-psychotic anxiety, following pretreatment with benzodiazepines. Psychopharmacology (Berl) 2001;157:277-283. (Pubitemid 32905569)
160. Boerner RJ, Sommer H, Berger W, et al. Kava-kava extract LI 150 is as effective as opipramol and buspirone in generalised anxiety disorder - an 8-week randomized, double-blind multi-centre clinical trial in 129 out-patients. Phytomedicine 2003;10:38-49. (Pubitemid 36597155)
161. Geier FP, Konstantinowicz T. Kava treatment in patients with anxiety. Phytother Res 2004;18:297-300.
162. Wolfson P, Hoffmann DL. An investigation into the efficacy of Scutellaria lateriflora in healthy volunteers. Altern Ther Health Med 2003;9:74-78. (Pubitemid 36286409)
163. Jiang JG, Huang XJ, Chen J. Separation and purification of saponins from semen Ziziphus jujuba and their sedative and hypnotic effects. J Pharm Pharmacol 2007;59:1175-1180. (Pubitemid 47265367)
164. Jiang JG, Huang XJ, Chen J, Lin QS. Comparison of the sedative and hypnotic effects of flavonoids, saponins, and polysaccharides extracted from semen Ziziphus jujube. Nat Prod Res 2007;21:310-320. (Pubitemid 46729927)
165. Wang LE, Bai YJ, Shi XR, et al. Spinosin, a C-glycoside flavonoid from semen Zizhiphi spinozae, potentiated pentobarbital-induced sleep via the serotonergic system. Pharmacol Biochem Behav 2008;90:399-403.
166. Peng WH, Hsieh MT, Lee YS, et al. Anxiolytic effect of seed of Ziziphus jujuba in mouse models of anxiety. J Ethnopharmacol 2000;72:435-441. (Pubitemid 30734677)
167. Smith TA. Type A gamma-aminobutyric acid (GABAA) receptor subunits and benzodiazepine binding: significance to clinical syndromes and their treatment. Br J Biomed Sci 2001;58:111-121. (Pubitemid 32566041)
168. Nemeroff CB. The role of GABA in the pathophysiology and treatment of anxiety disorders. Psychopharmacol Bull 2003;37:133-146.
169. Kendell SF, Krystal JH, Sanacora G. GABA and glutamate systems as therapeutic targets in depression and mood disorders. Expert Opin Ther Targets 2005;9:153-168. (Pubitemid 40331202)
170. Kugaya A, Sanacora G. Beyond monoamines: glutamatergic function in mood disorders. CNS Spectr 2005;10:808-819. (Pubitemid 41531934)
171. Krystal JH, Sanacora G, Blumberg H, et al. Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments. Mol Psychiatry 2002;7:S71-S80. (Pubitemid 34280651)
172. Gottesmann C. GABA mechanisms and sleep. Neuroscience 2002;111:231-239.
173. Nutt D. GABAA receptors: subtypes, regional distribution, and function. J Clin Sleep Med 2006;2:S7-S11. (Pubitemid 43893278)
174. Spila B, Szumillo A. Gabapentin (GBP) in panic disorders - case report. Psychiatr Pol 2006;40:1061-1068. [Article in Polish] (Pubitemid 46225066)
175. Streeter CC, Jensen JE, Perlmutter RM, et al. Yoga asana sessions increase brain GABA levels: a pilot study. J Altern Complement Med 2007;13:419-426. (Pubitemid 46802346)
176. Khom S, Baburin I, Timin E, et al. Valerenic acid potentiates and inhibits GABA(A) receptors: molecular mechanism and subunit specificity. Neuropharmacology 2007;53:178-187. (Pubitemid 47125958)
177. Geuze E, van Berckel BN, Lammertsma AA, et al. Reduced GABAA benzodiazepine receptor binding in veterans with post-traumatic stress disorder. Mol Psychiatry 2008;13:74-83. (Pubitemid 350275183)
178. Unpublished data provided by Pharma Foods International LTD., Kyoto, Japan.
179. Abdou AM, Higashiguchi S, Horie K, et al. Relaxation and immunity enhancement effects of gamma aminobutyric acid (GABA) administration in humans. Biofactors 2006;26:201-208. (Pubitemid 44359508)
180. Green ML, Green RG, Santoro W. Daily relaxation modifies serum and salivary immunoglobulins and psychophysiologic symptom severity. Biofeedback Self Regul 1988;13:187-199. (Pubitemid 19039071)
181. Orser BA. Extrasynaptic GABAA receptors are critical targets for sedative-hypnotic drugs. J Clin Sleep Med 2006;2:S12-S18. (Pubitemid 43893279)
182. Palagini L, Campbell IG, Tan X, et al. Independence of sleep EEG responses to GABAergic hypnotics: biological implications. J Psychiatr Res 2000;34:293-300. (Pubitemid 30847488)
183. Roth T, Soubrane C, Titeux L, et al. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia. Sleep Med 2006;7:397-406. (Pubitemid 44103494)
184. Bazil CW, Battista J, Basner RC. Gabapentin improves sleep in the presence of alcohol. J Clin Sleep Med 2005;1:284-287.
185. Schneider-Helmert D, Spinweber CL. Evaluation of L-tryptophan for treatment of insomnia: a review. Psychopharmacology (Berl) 1986;89:1-7. (Pubitemid 16062953)
186. Korner E, Bertha G, Flooh E, et al. Sleep-inducing effect of L-tryptophane. Eur Neurol 1986;25:75-81.
187. Hartmann E, Spinweber CL. Sleep induced by L-tryptophan. Effect of dosages within the normal dietary intake. J Nerv Ment Dis 1979;167:497-499. (Pubitemid 9227139)
188. Schmidt HS. L-tryptophan in the treatment of impaired respiration in sleep. Bull Eur Physiopathol Respir 1983;19:625-629. (Pubitemid 14223649)
189. Lieberman HR, Corkin S, Spring BJ, et al. The effects of dietary neurotransmitter precursors on human behavior. Am J Clin Nutr 1985;42:366-370.
190. Hussain AM, Mitra AK. Effect of aging on tryptophan hydroxylase in rat brain: implications on serotonin level. Drug Metab Dispos 2000;28:1038-1042. (Pubitemid 30660357)
191. van Praag HM, Lemus C. Monoamine precursors in the treatment of psychiatric disorders. In: Wurtman RJ, Wurtman JJ, eds. Nutrition and the Brain. New York, NY: Raven Press; 1986:89-139.
192. den Boer JA, Westenberg HG. Behavioral, neuroendocrine, and biochemical effects of 5-hydroxytryptophan administration in panic disorder. Psychiatry Res 1990;31:267-278. (Pubitemid 20102375)
193. Chadwick D, Jenner P, Harris R, et al. Manipulation of brain serotonin in the treatment of myoclonus. Lancet 1975;2:434-435.
194. Maron E, Toru I Vasar V, Shlik J. The effect of 5-hydroxytryptophan on cholecystokinin-4-induced panic attacks in healthy volunteers. J Psychopharmacol 2004;18:194-199. (Pubitemid 38954906)
195. Schruers K, van Diest R, Overbeek T, Griez E. Acute L-5-hydroxytryptophan administration inhibits carbon dioxide-induced panic in panic disorder patients. Psychiatry Res 2002;113:237-243. (Pubitemid 36136046)
196. Bruni O, Ferri R, Miano S, Verrillo E. L-5-hydroxytryptophan treatment of sleep terrors in children. Eur J Pediatr 2004;163:402-407. (Pubitemid 38916377)
197. Armstrong SM. Melatonin. The internal zeitgeber of mammals? Pineal Res Rev 1989;7:157-202.
198. Attenburrow ME, Dowling BA, Sharpley AL, Cowen PJ. Case-control study of evening melatonin concentration in primary insomnia. BMJ 1996;312:1263-1264. (Pubitemid 26147664)
199. Dahlitz M, Alvarez B, Vignau J, et al. Delayed sleep phase syndrome response to melatonin. Lancet 1991;337:1121-1124.
200. Oldani A, Ferini-Strambi L, Zucconi M, et al. Melatonin and delayed sleep phase syndrome: ambulatory polygraphic evaluation. Neuroreport 1994;6:132-134.
201. Owasoyo JO, Neri DF, Lamberth JG. Tyrosine and its potential use as a countermeasure to performance decrement in military sustained operations. Aviat Space Environ Med 1992;63:364-369.
202. Salter CA. Dietary tyrosine as an aid to stress resistance among troops. Mil Med 1989;154:144-146. (Pubitemid 19077914)
203. Neri DF, Wiegmann D, Stanny RR, et al. The effects of tyrosine on cognitive performance during extended wakefulness. Aviat Space Environ Med 1995;66:313-319.
204. Deijen JB, Wientjes CJ, Vullinghs HF, et al. Tyrosine improves cognitive performance and reduces blood pressure in cadets after one week of a combat training course. Brain Res Bull 1999;48:203-209. (Pubitemid 29177395)
205. Shurtleff D, Thomas JR, Schrot J, et al. Tyrosine reverses a cold-induced working memory deficit in humans. Pharmacol Biochem Behav 1994;47:935-941. (Pubitemid 24119904)
206. Banderet LE, Lieberman HR. Treatment with tyrosine, a neurotransmitter precursor, reduces environmental stress in humans. Brain Res Bull 1989;22:759-762.
207. Mahoney CR, Castellani J, Kramer FM, et al. Tyrosine supplementation mitigates working memory decrements during cold exposure. Physiol Behav 2007;92:575-582. (Pubitemid 350016120)
208. Deijen JB, Orlebeke JF. Effect of tyrosine on cognitive function and blood pressure under stress. Brain Res Bull 1994;33:319-323. (Pubitemid 124010050)
209. Dollins AB, Krock LP, Storm WF, et al. L-tyrosine ameliorates some effects of lower body negative pressure stress. Physiol Behav 1995;57:223-230.
210. Robinson CR, Pegram GV, Hyde PR, et al. The effects of nicotinamide upon sleep in humans. Biol Psychiatry 1977;12:139-143. (Pubitemid 8055068)
211. Kosaka C, Okida M, Kaneyuki T, et al. Action of pantethine on the adrenal cortex of hypophysectomized rats. Horumon To Rinsho 1973;21:517-525. [Article in Japanese]
212. Onuki M, Hoshino H. Effect of pantethine on the adrenocortical function. 1. Experimental results using rabbits. Horumon To Rinsho 1970;18:601-605. [Article in Japanese]
213. Kosaka M, Kikui S, Fujiwara T, Kimoto T. Action of pantethine on the adrenal cortex. Horumon To Rinsho 1966;14:843-847. [Article in Japanese]
214. Onuki M, Suzawa A. Effect of pantethine on the function of the adrenal cortex. 2. Clinical experience using pantethine in cases under steroid hormone treatment. Horumon To Rinsho 1970;18:937-940. [Article in Japanese]
215. Ralli D. NYU Bellevue Med Center, 1952. [Abstract]
216. Honma K, Kohsaka M, Fukuda N, et al. Effects of vitamin B12 on plasma melatonin rhythm in humans: increased light sensitivity phase-advances the arcadian clock? Experientia 1992;48:716-720.
217. Hashimoto S, Kohsaka M, Morita N, et al. Vitamin B12 enhances the phase-response of circadian melatonin rhythm to a single bright light exposure in humans. Neurosci Lett 1996;220:129-132. (Pubitemid 26426601)
218. Uchiyama M, Mayer G, Okawa M, Meier-Ewert K. Effects of vitamin B12 on human circadian body temperature rhythm. Neurosci Lett 1995;192:1-4.
219. Ohta T, Iwata T, Kayukawa Y, Okada T. Daily activity and persistent sleep-wake schedule disorders. Prog Neuropsychopharmacol Biol Psychiatry 1992;16:529-537.
220. Ohta T, Ando K, Iwata T, et al. Treatment of persistent sleep-wake schedule disorders in adolescents with methylcobalamin (vitamin B12). Sleep 1991;14:414-418.
221. Tomoda A, Miike T, Matsukura M. Circadian rhythm abnormalities in adrenoleukodystrophy and methyl B12 treatment. Brain Dev 1995;17:428-431. (Pubitemid 26004806)
222. Anderson DN, Abou-Saleh MT, Collins J, et al. Pterin metabolism in depression: an extension of the amine hypothesis and possible marker of response to ECT. Psychol Med 1992;22:863-869. (Pubitemid 23006997)
223. Heller R, Unbehaun A, Schellenberg B, et al. L-ascorbic acid potentiates endothelial nitric oxide synthesis via a chemical stabilization of tetrahydrobiopterin. J Biol Chem 2001;276:40-47. (Pubitemid 32050286)
224. Nakai K, Urushihara M, Kubota Y, Kosaka H. Ascorbate enhances iNOS activity by increasing tetrahydrobiopterin in RAW 264.7 cells. Free Radic Biol Med 2003;35:929-937. (Pubitemid 37211447)
225. Gromova EG, Sviridova SP, Kushlinskii NE, et al. Regulation of the indices of neuroendocrine status in surgical patients with lung cancer using optimal doses of ascorbic acid. Anesteziol Reanimatol 1990;5:71-74. [Article in Russian]
226. Liakakos D, Doulas NL, Ikkos D, et al. Inhibitory effect of ascorbic acid (vitamin C) on cortisol secretion following adrenal stimulation in children. Clin Chim Acta 1975;65:251-255.
227. Shelygina NM, Spivak RIa, Zaretskii MM, et al. Influence of vitamins C, B1, and B6 on the diurnal periodicity of the glucocorticoid function of the adrenal cortex in patients with atherosclerotic cardiosclerosis. Vopr Pitan 1975;2:25-29. [Article in Russian]